Etripamil
Milestone Pharma
['cardio', 'lbs,08', 'anheart']
open access: rationale &amp; design of a multicenter, placebo-controlled, phase 3 study to assess efficacy &amp; safety of intranasal etripamil for conversion of paroxysmal supraventricular tachycardia. #aha22 #epeeps #cardiotwitter lbs.08. mon nov 7, 11am-noon 
The American Heart Journal has been a trusted resource for cardiologists and general practice physicians for more than 80 years